MicroRNA-204-5p Inhibits Hepatocellular Carcinoma by Targeting the Regulator of G Protein Signaling 20
Open Access
- 6 November 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 6 (12) , 1817-1828
Abstract
Although the oncogenic roles of regulator of G protein signaling 20 (RGS20) and its upstream microRNAs (miRNAs) have been reported, their involvement in hepatocellular carcinoma (HCC) remains unexplored. We utilized the starBase, miRDB, TargetScan, and mirDIP databases, along with a dual-luciferase reporter assay and cDNA chip analysis to identify miRNAs targeting RGS20. miR-204-5p was selected for further experiments to confirm its direct targeting and downregulation of the RGS20 expression. To study the miR-204-5p/RGS20 axis in HCC, RGS20 and miR-204-5p were increased in PLC/PRF/5/Hep3B cells, and the viability, hyperplasia, apoptosis, cell cycle, and invasion/migration of the cells were assessed. RGS20 exhibited optimism, while miR-204-5p exhibited pessimism in tumors. miR-204-5p directly targeted RGS20 and downregulated its expression, whereas high RGS20 expression indicated a poor prognosis. Transfection of miR-204-5p inhibited the hyperplasia, migration, and invasion of HCC cells, but promoted apoptosis and influenced the levels of cyclin-dependent kinase 2 (CDK2), cyclin E1, B-cell lymphoma-2 (Bcl-2), Bax, and cleaved caspase-3/8. These effects were reversed by overexpression of RGS20. We recognized miR-204-5p as an upstream regulator targeting RGS20, thereby inhibiting HCC progression by downregulating RGS20 expression. RGS20 may prove to be a potential target for HCC treatment, and miR-204-5p might seem like to be a potential miRNA in gene therapy.Keywords
Funding Information
- Natural Science Foundation of Fujian Province (2020J01748, 2022J01368)
- National Natural Science Foundation of China (82204925)
This publication has 44 references indexed in Scilit:
- Functional mechanism and clinical implications of MicroRNA‐423 in human cancersCancer Medicine, 2020
- LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axisBiomedicine & Pharmacotherapy, 2020
- Systemic Adjuvant Treatment in Hepatocellular Carcinoma: Tempted to do Something Rather than NothingFuture Oncology, 2020
- RETRACTED ARTICLE: HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axisOncogene, 2020
- MicroRNA‐520e targets AEG‐1 to suppress the proliferation and invasion of colorectal cancer cells through Wnt/GSK‐3β/β‐catenin signallingClinical and Experimental Pharmacology and Physiology, 2019
- Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA networkOncoTargets and Therapy, 2018
- lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR‑365/RGS20 in oral squamous cell carcinomaOncology Reports, 2018
- miR‐204‐5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expressionFEBS Open Bio, 2017
- miR‐204‐5p targeting SIRT1 regulates hepatocellular carcinoma progressionCell Biochemistry and Function, 2016
- MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK)Oncogene, 2011